Case Report: Successful treatment of drug-resistant epilepsy with unilateral deep brain stimulation of the anterior nucleus of the thalamus
4 affiliations
- 1Department of Neurosurgery, Nara Medical University
- 2Department of Neurosurgery, National Hospital Organization Nara Medical Center
- 3Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University
- 4Department of Neurology, National Hospital Organization Wakayama Hospital
Abstract
Background: Deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) is an established palliative treatment for drug-resistant epilepsy (DRE) and is conventionally performed bilaterally. However, the efficacy of unilateral ANT-DBS remains unclear. We report a patient with DRE who underwent unilateral ANT-DBS because of an epileptogenic network predominantly involving one side and anatomical constraints precluding electrode implantation on the contralateral side.
Methods: A 29-year-old female underwent comprehensive presurgical evaluation, including seizure semiology assessment, video-electroencephalography (EEG), computed tomography, and magnetic resonance imaging. She developed DRE following multimodal treatment for a suprasellar germ cell tumor during childhood. Despite multiple antiseizure medications and vagus nerve stimulation, she continued to experience approximately 10 habitual seizures per day.
Results: Seizure semiology was characterized by asymmetric tonic posturing of the limbs lasting 10–30 s, followed by an atonic phase. EEG findings indicated a widespread epileptogenic network predominantly involving the right frontal and temporal areas. Brain imaging showed severe left hemispheric atrophy, marked widening of the left subdural space, and a pre-existing shunt system, which prevented identification of the left ANT. Therefore, DBS implantation was performed in the right ANT alone. Stimulation was initiated 7 days after surgery at an intensity of 2 mA. Following initiation of right ANT stimulation, seizure frequency decreased from approximately 10 to one per day, likely due to a microlesioning effect. Thereafter, right ANT stimulation was associated with a sustained seizure reduction of approximately 60%. Postoperative EEG demonstrated a reduction in interictal epileptiform discharges. The clinical benefit was maintained at the 9-month follow-up, with no surgery- or stimulation-related adverse events were observed.
Conclusion: Unilateral ANT-DBS can provide clinically meaningful seizure control in carefully selected patients whose predominant epileptogenic network is localized to one cerebral hemisphere. This approach may represent a feasible therapeutic option when anatomical or surgical constraints prevent conventional bilateral ANT electrode implantation. Further studies with larger patient cohorts and longer follow-up periods are required to clarify the indications, durability, and efficacy of unilateral ANT-DBS.
Related
- Fronto-temporal transcranial direct current stimulation reduces symptoms in treatment-resistant schizophrenia: a randomized sham-controlled trial
- The application of transcranial magnetic stimulation in treatment-resistant depression: insights from omics
- Nucleus Accumbens-Anterior Limb of Internal Capsule Deep Brain Stimulation for Treatment-Resistant Schizophrenia: An Open-label Pilot Study
- Long-term outcomes of nucleus accumbens/anterior limb of the internal capsule deep brain stimulation in treatment-resistant obsessive-compulsive disorder
- Repetitive transcranial magnetic stimulation for treatment-resistant depression in Singapore: a retrospective, naturalistic study
BibTeX
@article{sasaki2026case,
title = {{Case Report: Successful treatment of drug-resistant epilepsy with unilateral deep brain stimulation of the anterior nucleus of the thalamus}},
author = {Ryota Sasaki and Kengo Yamada and Kentaro Tamura and Masako Kinoshita and Young-Soo Park and Abbas F. Sadikot and Ichiro Nakagawa},
journal = {Frontiers in Neuroscience},
year = {2026},
month = oct,
doi = {10.3389/fnins.2026.1978183},
url = {https://www.frontiersin.org/articles/10.3389/fnins.2026.1978183/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Case Report: Successful treatment of drug-resistant epilepsy with unilateral deep brain stimulation of the anterior nucleus of the thalamus
AU - Ryota Sasaki
AU - Kengo Yamada
AU - Kentaro Tamura
AU - Masako Kinoshita
AU - Young-Soo Park
AU - Abbas F. Sadikot
AU - Ichiro Nakagawa
PY - 2026
DA - 2026/10/19
JO - Frontiers in Neuroscience
DO - 10.3389/fnins.2026.1978183
UR - https://www.frontiersin.org/articles/10.3389/fnins.2026.1978183/full
AB - Background: Deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) is an established palliative treatment for drug-resistant epilepsy (DRE) and is conventionally performed bilaterally. However, the efficacy of unilateral ANT-DBS remains unclear. We report a patient with DRE who underwent unilateral ANT-DBS because of an epileptogenic network predominantly involving one side and anatomical constraints precluding electrode implantation on the contralateral side. Methods: A 29-year-old female underwent comprehensive presurgical evaluation, including seizure semiology assessment, video-electroencephalography (EEG), computed tomography, and magnetic resonance imaging. She developed DRE following multimodal treatment for a suprasellar germ cell tumor during childhood. Despite multiple antiseizure medications and vagus nerve stimulation, she continued to experience approximately 10 habitual seizures per day. Results: Seizure semiology was characterized by asymmetric tonic posturing of the limbs lasting 10–30 s, followed by an atonic phase. EEG findings indicated a widespread epileptogenic network predominantly involving the right frontal and temporal areas. Brain imaging showed severe left hemispheric atrophy, marked widening of the left subdural space, and a pre-existing shunt system, which prevented identification of the left ANT. Therefore, DBS implantation was performed in the right ANT alone. Stimulation was initiated 7 days after surgery at an intensity of 2 mA. Following initiation of right ANT stimulation, seizure frequency decreased from approximately 10 to one per day, likely due to a microlesioning effect. Thereafter, right ANT stimulation was associated with a sustained seizure reduction of approximately 60%. Postoperative EEG demonstrated a reduction in interictal epileptiform discharges. The clinical benefit was maintained at the 9-month follow-up, with no surgery- or stimulation-related adverse events were observed. Conclusion: Unilateral ANT-DBS can provide clinically meaningful seizure control in carefully selected patients whose predominant epileptogenic network is localized to one cerebral hemisphere. This approach may represent a feasible therapeutic option when anatomical or surgical constraints prevent conventional bilateral ANT electrode implantation. Further studies with larger patient cohorts and longer follow-up periods are required to clarify the indications, durability, and efficacy of unilateral ANT-DBS.
SN - 1662-453X
SN - 1662-4548
ER -